Drug Discovery Today

Crossing the blood-brain barrier: are we getting it right?
pp. 1-2(2)
Author: Pardridge W.M.

Mouse model for Burkitt's lymphoma will aid understanding and therapy
pp. 3-4(2)
Author: Hillery A.

Welcome to the news
pp. 3-3(1)
Author: Lawrence R.N.

What the industry says
pp. 5-5(1)
Author: Lawrence R.

Encapsulated cell technology provides new treatment options
pp. 6-7(2)
Author: Senior K.

Targets and mechanisms
pp. 8-9(2)
Authors: Hinde A.; Ramster B.; Owens J.; Lawrence R.N.

People
pp. 9-9(1)

Craig Venter discusses life after the Human Genome Project - Interviewed by Rebecca Lawrence
pp. 10-12(3)
Author: Lawrence R.

David Bentley discusses life after the Human Genome Project - Interviewed by Rebecca Lawrence
pp. 13-14(2)
Author: Lawrence R.

Computational approaches in the post-genomic era - how will we cope?
pp. 15-16(2)
Authors: Lahana R.; Church D.J.; Terrett N.

Discovering drugs for heart failure?
pp. 17-18(2)
Author: Hinde A.

Open day review: bridging the gap between academia and industry
pp. 19-20(2)
Authors: Roberts P.J.; Kozlowski R.Z.

Quo vadis, biotech? (Part 2)
pp. 21-26(6)
Author: Drews J.

Carbohydrate sulfotransferases: novel therapeutic targets for inflammation, viral infection and cancer
pp. 27-35(9)
Author: Hemmerich S.

Antibody libraries in drug and target discovery
pp. 36-43(8)
Author: Rader C.

Folate-mediated targeting: from diagnostics to drug and gene delivery
pp. 44-51(8)
Authors: Leamon C.P.; Low P.S.

Monitor: molecules and profiles
pp. 52-53(2)
Authors: Barrett D.; Langston S.

Combinatorial chemistry
pp. 54-55(2)
Author: Edwards P.